Table 4. Additional detailed analysis for comparison of the proportion achieving a two-point score in 11 items.
RS group (n = 99) |
CL group (n = 101) |
|||||
Number achieving a two-point score | % | Number achieving a two-point score | % | P value (Fisher's exact test) | Evaluation | |
Ph | 99 | 100.0 % | 97 | 96.0 % | 0.121 | n.s. |
Pb | 99 | 100.0 % | 101 | 100.0 % | N/A | n.s. |
Phb | 88 | 88.9 % | 99 | 98.0 % | 0.010 | S |
Pt | 99 | 100.0 % | 100 | 99.0 % | 1.000 | n.s. |
Papilla | 41 | 41.4 % | 19 | 18.8 % | 0.001 | I |
BD (Bmi) | 90 | 90.9 % | 91 | 90.1 % | 1.000 | n.s. |
BD (Bsp) | 7 | 7.1 % | 79 | 78.2 % | < 0.001 | S |
CD | 85 | 85.9 % | 83 | 82.2 % | 0.564 | n.s. |
GB | 47 | 47.5 % | 13 | 12.9 % | < 0.001 | I |
CA | 89 | 89.9 % | 101 | 100.0 % | 0.001 | S |
SMA | 62 | 62.6 % | 101 | 100.0 % | < 0.001 | S |
Ph, pancreatic head; Pb, pancreatic body; Phb, pancreatic neck; Pt, pancreatic tail; BD, bile duct; Bmi, from middle to lower bile duct; Bsp, from superior bile duct to the hepatic portal region; CD, cystic duct; GB, gallbladder; CA, celiac artery; SMA, superior mesenteric artery; N/A, not applicable; n.s., non-significant difference; I, inferiority; S, superiority.